Early research (Phase 1)Looking for participantsNCT03541889What this trial is testingREVEAL Biomarkers of Engraftment After Alternative Donor HSCTWho this might be right forPrimary Graft Failure University of Oklahoma 50
Testing effectiveness (Phase 2)Ended earlyNCT00358657What this trial is testingFludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited DisordersWho this might be right forImmunodeficiency SyndromeSevere Aplastic AnemiaGenetic Disorder Fred Hutchinson Cancer Center 14
Not applicableStudy completedNCT06125535What this trial is testingBiomolecular Phenotyping of Lung Transplant RecipientsWho this might be right forLung Transplant Failure Policlinico Hospital 80
Not applicableEnded earlyNCT04558333What this trial is testingCLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung TransplantationWho this might be right forLung Transplant Failure and RejectionPrimary Graft Dysfunction University Hospital, Antwerp 24
Not applicableUnknownNCT03156894What this trial is testingHeart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg ExperienceWho this might be right forPrimary Graft Dysfunction University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)Ended earlyNCT00005852What this trial is testingBone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more H. Lee Moffitt Cancer Center and Research Institute
Large-scale testing (Phase 3)UnknownNCT03389919What this trial is testingIntraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCTWho this might be right forMesenchymal Stem Cell Transplantation National Research Center for Hematology, Russia 20
Large-scale testing (Phase 3)Ended earlyNCT00895479What this trial is testingAdenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control EvidenceWho this might be right forEnd Stage Renal Disease Ark Therapeutics Ltd 250
Post-approval studies (Phase 4)Study completedNCT01172418What this trial is testingRandomized Trial of 2 Antibody Induction Steroid Avoidance ProtocolsWho this might be right forTransplant; Failure, Kidney University of Miami 200
Early research (Phase 1)Looking for participantsNCT06047886What this trial is testingUAB 2419-CD34 Selection Using the Automated CliniMACS ProdigyWho this might be right forAMLALLLymphoid Malignancies+3 more University of Alabama at Birmingham 50
Not applicableLooking for participantsNCT06569082What this trial is testingCD34+ Selected Stem Cell for Poor Graft Function or Graft FailureWho this might be right forGraft FailurePoor Graft Function NYU Langone Health 21
Testing effectiveness (Phase 2)Study completedNCT01394497What this trial is testingUse of N-Acetylcysteine During Liver ProcurementWho this might be right forLiver FailureLiver Failure, AcuteLiver Diseases+2 more Azienda Ospedaliera di Padova 140
Testing effectiveness (Phase 2)Study completedNCT02065154What this trial is testingPost Transplant Cyclophosphamide (Cytoxan) for GvHD ProphylaxisWho this might be right forLeukemiaLymphomaMyelodysplastic Syndrome+3 more University of Alabama at Birmingham 39
Not applicableStudy completedNCT03858088What this trial is testingEarly Allograft Failure Simplified Estimation (EASE) in Liver TransplantationWho this might be right forLiver Transplant Failure Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,350
Large-scale testing (Phase 3)Looking for participantsNCT07079735What this trial is testingValganciclovir vs. Letermovir for CMV Prophylaxis in Heart TransplantWho this might be right forCMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection Columbia University 150
Not applicableAvailableNCT06731036What this trial is testingExpanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell BoostsWho this might be right forSevere Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more University of Florida
Post-approval studies (Phase 4)Study completedNCT06605326What this trial is testingSubcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective StudyWho this might be right forPulmonary HypertensionPulmonary Arterial HypertensionChronic Lung Disease-Associated Pulmonary Hypertension+2 more Guangzhou Institute of Respiratory Disease 46